Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
18.05
0.00 (0.00%)
Aug 13, 2025, 4:00 PM - Market open
Travere Therapeutics Employees
Travere Therapeutics had 385 employees as of December 31, 2024. The number of employees increased by 5 or 1.32% compared to the previous year.
Employees
385
Change (1Y)
5
Growth (1Y)
1.32%
Revenue / Employee
$867,182
Profits / Employee
-$439,106
Market Cap
1.61B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TVTX News
- 1 day ago - Travere Therapeutics: Compelling FILSPARI Growth Is Hard To Ignore - Seeking Alpha
- 2 days ago - Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 days ago - Travere Therapeutics, Inc. (TVTX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Travere Therapeutics Reports Second Quarter 2025 Financial Results - Business Wire
- 8 days ago - Travere Therapeutics to Participate at Upcoming Investor Conferences - Business Wire
- 14 days ago - Travere Therapeutics to Report Second Quarter 2025 Financial Results - Business Wire
- 2 months ago - Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 15th International Podocyte Conference - Business Wire
- 2 months ago - Travere Therapeutics Launches "Play It Forward" Campaign to Celebrate the FSGS Community on Inaugural Awareness Day - Business Wire